arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Co-Diagnostics, Inc.

CODX
$1.09 0.00 (-0.46%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
42 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Co-Diagnostics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.7M
Dividend Yield —
Revenue Growth 2.0% ↘
Op. Margin None
ROIC -48.9% ↗
FCF / Share $-1.66 ↗
Trailing P/E —
Price / Book 0.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$166.13K
↑ +2.0% —
Net Income Profit after all expenses
$-9.14M
↓ -21.3% —
Operating Margin Operating profit as % of sales
-289.1%
↑ +13.1% —
FCF / Share Free cash flow per share
$-1.66
↑ +53.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Cash Quality ↓
46

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 42 quarters